Hepatology

General Hepatology

Questions discussed in this category

How do you determine whether to limit volume removal during therapeutic paracentesis in a patient without acute or chronic kidney disease?

1 Answer available

Do you recommend starting naltrexone at discharge for alcohol use disorder in patients with decompensated cirrhosis secondary to alcohol use?

1 Answer available

What is your clinical approach to the evaluation of cytopenias in patients with end-stage liver disease?

1 Answer available

How do you approach HCC screening in patients with advanced fibrosis e.g., F3 on FibroScan?

1 Answer available

When giving albumin challenge, for acute kidney injury with suspected hepatorenal syndrome, do you administer a single dose daily or split the dose of albumin?

1 Answer available

How do you approach the use of viscoelastic assays (ex: TEG, ROTEM) in patients with identified coagulopathy in the peri-procedural period?

1 Answer available

What parameters would you use to monitor and interpret iron levels in a hemochromatosis patient where ferritin is unreliable due to underlying chronic inflammation?

How would your recommendation change if the patient has H63 homozygous mutation?

2 Answers available

When would you consider use of EUS guided liver biopsy over percutaneous and/or transjugular?

2 Answers available

If you do not have easy access to shear wave elastography (aka Fibroscan), what do you recommend for non-invasive tests to determine if a MASLD patient has clinically significant portal hypertension and risk-stratify them?

1 Answer available

How do you approach dosing beta blockers for variceal prophylaxis when the standard dose doesn’t achieve the target heart rate?"

1 Answer available

How do you approach a patient who has incidentally found liver and renal cysts?

1 Answer available

Do you avoid peritoneal dialysis in cirrhotic patients with ascites?

3 Answers available

Do you obtain liver biopsy to confirm the diagnosis of cirrhosis if cirrhotic liver morphology is noted on imaging?

2 Answers available

Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?

1 Answer available

Papers discussed in this category

International journal of molecular sciences, 2022 Mar 13

SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection.

Medicine, 2016 Jan

Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease.

Clinical nephrology, 2011 Oct

Outcome of peritoneal dialysis in cirrhotic patients with end-stage renal disease: a 24-years' experience in Taiwan.

The American journal of medicine, 1992 Jul

Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002 Jul

Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure.

Hepatology (Baltimore, Md.), 2023 Oct 23

AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis.

The New England journal of medicine, 2021 Mar 04

A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.

Hepatology

General Hepatology

Questions discussed in this category

Papers discussed in this category

Related Topics in Hepatology